THE IMPACT OF CHANGING TOTAL KNEE ARTHROPLASTY IMPLANTS AT A HIGH-VOLUME INSTITUTION

The ability of a group of high-volume arthroplasty surgeons to simultaneously change their preferred primary total knee arthroplasty (TKA) implant of choice to another, has not been explored in the literature to date. The main hypothesis was that such a change could be made with no significant impact on clinical outcomes. This is a retrospective cohort study comparing the last 500 consecutive TKAs implanted of a routinely used TKA implant (NexGen; Zimmer, Warsaw, IN) with the first 500 consecutive TKAs implanted of a newly adopted TKA implant (Triathlon; Stryker, Mahwah, NJ) at an institutional level. Primary outcomes of importance included all complications that occurred either intraoperatively or early postoperatively, early all-cause revision rate, and early reintervention rate. There was a 1.2% (n = six) complication rate in the NexGen cohort compared to 0.8% (n = four) in the newly adopted Triathlon cohort (P = 0.75). The rate of intraoperative fracture was 1% (n = five) in the NexGen cohort and 0.6% (n = three) in the Triathlon cohort (P = 0.72). The early all-cause revision rate for the NexGen TKA was 1% (n = five) compared to 0.8% (n = four) in the Triathlon cohort (P = 1.0). The manipulation under anesthesia (MUA) rate in the NexGen cohort was 2.4% (n = 12) compared to 4.6% (n = 23) in the Triathlon cohort (P = 0.058). The only predictor variable associated with MUA rate was American Society of Anesthesiologists (ASA) grade, where there was a significantly lower rate of MUA with a higher ASA grade (P = 0.042). It is possible to implement the institution-wide adoption of an established, high-performing TKA implant without any negative implications in relation to early revision rates, perioperative complication rates, and reintervention rates. This study is the first of its kind to be reported in the literature.